Our latest News

discover more
FGK Clinical Research establishes operational presence in the Netherlands to bolster European clinical trial landscape

FGK Clinical Research establishes operational presence in the Netherlands to bolster European clinical trial landscape

[Munich, 10/03/2026] — FGK Clinical Research GmbH, a leading full-service Contract Research Organization (CRO) headquartered in Germany, is thrilled to announce the further expansion of its operative team in the Netherlands. This strategic regional expansion strengthens FGK’s European presence and commitment to high-quality clinical research services. The local Dutch team will support clinical studies in the […]

read more
Heidelberg Pharma and HealthCare Royalty Announce Amendment to Existing Royalty Agreement and the Participation of Soleus Capital

Heidelberg Pharma and HealthCare Royalty Announce Amendment to Existing Royalty Agreement and the Participation of Soleus Capital

Ladenburg, Germany, 9 March 2026 – Heidelberg Pharma AG (FSE: HPHA), a clinical stage biotech company developing innovative Antibody Drug Conjugates (ADCs), announced on 7 March an additional amendment to its existing royalty purchase agreement with HealthCare Royalty (HCRx) and the participation of Soleus Capital Management, L.P. (Soleus Capital), a US-based life sciences investment firm, on behalf […]

read more
A human mini-bladder shows the culprit of recurrent infections

A human mini-bladder shows the culprit of recurrent infections

Researchers at EPFL, Heidelberg University and Roche have built a human mini-bladder to show how urine composition weakens bladder tissue, helping infections recur even after antibiotics. The bladder is not just a static storage bag; its lining stretches, relaxes, and stays in constant contact with urine whose composition changes with hydration, diet, and disease. Urine […]

read more

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp